Showing results (131-140 of 268) with videos related to

Sort By:
Pageof 27
Journal of Viral Hepatitis|February 1, 2008
Liver cirrhosis in HIV-infected patients: prevalence, aetiology and clinical outcomeC Castellares, P Barreiro, L Martín-Carbonero, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 18, 2006
Prevalence of HIV-1 drug resistance mutations among Spanish prison inmatesJ García-Guerrero, P Sáiz de la Hoya, J Portilla, et al.
Medicina Oral, Patologia Oral Y Cirugia Bucal|October 10, 2020
Effect of zinc on oropharyngeal mucositis in children with acute leukemia undergoing chemotherapyR Gutiérrez-Vargas, M-Á Villasis-Keever, J Portilla-Robertson, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 5, 2002
Changes in bloodstream infections in HIV-positive patients in a university hospital in Spain (1995-1997)Ma L Pedro-Botet, J M Mòdol, X Vallés, et al.
The Journal of Infection|November 1, 1990
Visceral leishmaniasis in patients infected with human immunodeficiency virus. Co-operative Group for the Study of Leishmaniasis in AIDSC Montalban, J L Calleja, A Erice, et al.
Revista Espanola De Enfermedades Digestivas|March 1, 1994
[Influence of hepatitis C virus infection and human immunodeficiency on the natural history of chronic delta hepatitis]J Crespo, J L Lozano, S Echevarría, et al.
Anales De Medicina Interna (Madrid, Spain : 1984)|June 1, 1994
[Pulmonary hypertension secondary to multiple pulmonary thromboembolisms due to thrombosis of the right subclavian vein]F Ledesma Castaño, J F Campo Eschevarría, F Zurbano Goñi, et al.
Scandinavian Journal of Infectious Diseases|June 25, 1999
Short-term risk for AIDS-indicator diseases predicted by plasma HIV-1 RNA and CD4+ lymphocytesJ Romeu, M Balagué, L Ruiz, et al.
AIDS (London, England)|August 1, 1996
Resistance-related mutations in the HIV-1 protease gene of patients treated for 1 year with the protease inhibitor ritonavir (ABT-538)J C Schmit, L Ruiz, B Clotet, et al.
Medicina Clinica|April 10, 1979
[Granulomatous hepatitis. Etiologic study of 107 cases (author's transl)]J Vilaseca, J Guardia, A Cuxart, et al.
Pageof 27